Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease
- 1 October 1991
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 19 (2) , 95-102
- https://doi.org/10.1007/bf01980939
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cathepsin-D in Human Encjometrium: Induction by Progesterone and Potential Value as a Tumor Marker*Journal of Clinical Endocrinology & Metabolism, 1990
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Regulation of Cathepsin-D and pS2 Gene Expression by Growth Factors in MCF7 Human Breast Cancer CellsMolecular Endocrinology, 1989
- Progestin Effect on Cell Proliferation and 17β-Hydroxysteroid Dehydrogenase Activity in Normal Human Breast Cells in Culture*Journal of Clinical Endocrinology & Metabolism, 1986
- DISTRIBUTION OF THE MR52,000 ESTROGEN-REGULATED PROTEIN IN BENIGN BREAST DISEASES AND OTHER TISSUES BY IMMUNOHISTOCHEMISTRY1986
- IMMUNOHISTOCHEMICAL DETECTION OF THE ESTROGEN-REGULATED 52,000 mol wt PROTEIN IN PRIMARY BREAST CANCERS BUT NOT IN NORMAL BREAST AND UTERUSJournal of Clinical Endocrinology & Metabolism, 1984
- The estrogenic and antiestrogenic activities of androgens in female target tissuesPharmacology & Therapeutics, 1983
- Antiestrogenic Effect of R5020, a Synthetic Progestin in Human Breast Cancer Cells in Culture*Journal of Clinical Endocrinology & Metabolism, 1983
- Heavy metal intensification of DAB-based HRP reaction product.Journal of Histochemistry & Cytochemistry, 1981
- PLASMA LEVELS OF NORETHINDRONE AFTER SINGLE ORAL DOSE ADMINISTRATION OF NORETHINDRONE AND LYNESTRENOLClinical Endocrinology, 1979